Published in Clin Neurophysiol on December 01, 2003
Small-fibre neuropathies--advances in diagnosis, pathophysiology and management. Nat Rev Neurol (2012) 1.19
Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. Mol Pain (2011) 1.09
Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96
Sarcoidosis and pain caused by small-fiber neuropathy. Pain Res Treat (2012) 0.79
Neuromuscular manifestations in hereditary haemochromatosis. J Neurol (2010) 0.78
Hypoxia induces no change in cutaneous thresholds for warmth and cold sensation. Eur J Appl Physiol (2008) 0.77
Neuropsychological impairment in amateur soccer players. JAMA (1999) 4.60
Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol (1992) 3.80
Determinants of success of inpatient clinical information systems: a literature review. J Am Med Inform Assoc (2003) 2.93
Chronic traumatic brain injury in professional soccer players. Neurology (1998) 2.25
[Guideline 'Diagnosis and treatment of carpal tunnel syndrome']. Ned Tijdschr Geneeskd (2008) 2.15
Efficacy of provocative tests for diagnosis of carpal tunnel syndrome. Lancet (1990) 2.15
Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med (1999) 2.03
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J (2008) 1.99
Risk factors for carpal tunnel syndrome. Am J Epidemiol (1990) 1.75
Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology (2012) 1.73
Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir Med (2000) 1.73
The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord (2000) 1.65
Anal dynamic graciloplasty in the treatment of intractable fecal incontinence. N Engl J Med (1995) 1.59
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol (2012) 1.57
Electrically stimulated gracilis sphincter for treatment of bladder sphincter incontinence. Lancet (1992) 1.46
Morphometry of dermal nerve fibers in human skin. Neurology (2011) 1.45
Pain relief and quality-of-life improvement after spinal cord stimulation in painful diabetic polyneuropathy: a pilot study. Br J Anaesth (2012) 1.44
Radial tunnel syndrome. An investigation of compression neuropathy as a possible cause. J Bone Joint Surg Am (1991) 1.44
[Cervical myelopathy as complication of manual therapy in a patient with a narrow cervical canal]. Ned Tijdschr Geneeskd (1993) 1.43
Nerve conduction studies show no exclusive ulnar or median innervation of the ring finger. Clin Neurophysiol (1999) 1.41
Evaluation of quality of life in sarcoidosis patients. Respir Med (1998) 1.40
[Value of treatment of low-grade glioma still controversial]. Ned Tijdschr Geneeskd (1994) 1.39
[Postsurgical pain and weakness in the shoulder-arm region: iatrogenic or not?]. Ned Tijdschr Geneeskd (2003) 1.38
[A case of fraud in a neurological pharmaceutical clinical trial]. Ned Tijdschr Geneeskd (2003) 1.38
An implanted neuromuscular stimulator for fecal continence following previously implanted gracilis muscle. Report of a case. Dis Colon Rectum (1988) 1.34
The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data. Neuromuscul Disord (2006) 1.33
A dose-response relation of headers and concussions with cognitive impairment in professional soccer players. J Clin Exp Neuropsychol (2001) 1.31
Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. J Neurol Neurosurg Psychiatry (2009) 1.29
Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology (2009) 1.24
Dynamic graciloplasty for treatment of faecal incontinence. Lancet (1991) 1.23
Hereditary muscular dystrophies and the heart. Neuromuscul Disord (2010) 1.21
Characterization of alpha-L-fucosidase from two different families with fucosidosis. Clin Chim Acta (1976) 1.20
Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci (2004) 1.19
The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients. J Neuroimmunol (2008) 1.16
Drug treatment for myotonia. Cochrane Database Syst Rev (2006) 1.11
Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus. Diabetes Obes Metab (2012) 1.08
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis (2011) 1.07
Schwartz-Jampel syndrome: II. Na+ channel defect causes myotonia. Muscle Nerve (1990) 1.07
[Thrombolytic therapy in patients with acute brain infarction: favorable preliminary results in Maastricht]. Ned Tijdschr Geneeskd (2000) 1.07
Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J (2001) 1.07
Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2012) 1.07
Development and implementation of an EPR: how to encourage the user. Int J Med Inform (2001) 1.06
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol (2013) 1.05
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology (2011) 1.05
Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil (1995) 1.05
Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis (2008) 1.01
Interobserver variation in the interpretation of SSEPs in anoxic-ischaemic coma. Clin Neurophysiol (2006) 1.01
Small fibre neuropathy in sarcoidosis. Lancet (2002) 1.01
Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies. J Neurol Neurosurg Psychiatry (2008) 0.99
Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms. Aliment Pharmacol Ther (2007) 0.99
Impaired balance control in paraplegic subjects. J Electromyogr Kinesiol (1997) 0.98
Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families. Neurology (2007) 0.98
The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands. Brain (1996) 0.98
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med (2011) 0.98
Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep (1993) 0.97
Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers. J Hosp Infect (1996) 0.97
Health status in non-dystrophic myotonias: close relation with pain and fatigue. J Neurol (2009) 0.96
Bronchoalveolar lavage fluid cytology in patients with Pneumocystis carinii pneumonia. Acta Cytol (2001) 0.96
Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. Neth J Med (1998) 0.95
Muscle ultrasound measurements and functional muscle parameters in non-dystrophic myotonias suggest structural muscle changes. Neuromuscul Disord (2009) 0.94
Accuracy and precision of quantitative calibrated loops in transfer of bronchoalveolar lavage fluid. J Clin Microbiol (2000) 0.94
Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol (2007) 0.94
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study. J Neurol Neurosurg Psychiatry (2007) 0.94
Dynamic cerebral autoregulation and cerebrovascular reactivity: a comparative study in lacunar infarct patients. Physiol Meas (2008) 0.93
Child psychiatric diagnoses in a population of Dutch schoolchildren aged 6 to 8 years. J Am Acad Child Adolesc Psychiatry (2001) 0.93
The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med (1997) 0.93
Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.93
Diagnostic value of BAL fluid cellular profile and enzymes in infectious pulmonary disorders. Eur Respir J (1999) 0.93
No effect of folic acid supplement on CSF folate and serum vitamin B12 in patients on anticonvulsants. Epilepsia (1970) 0.93
Isolated eyelid closure myotonia in two families with sodium channel myotonia. Neurogenetics (2009) 0.92
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology (2004) 0.92
Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum Genet (1981) 0.91
Forearm vascular response to nitric oxide and calcitonin gene-related peptide: comparison between migraine patients and control subjects. Cephalalgia (2006) 0.91
[Epilepsy and congenital anomalies]. Ned Tijdschr Geneeskd (1973) 0.90
Follow-up of anal dynamic graciloplasty for fecal continence. World J Surg (1993) 0.89
Denervation due to lesions of the central nervous system. An EMG study in cases of cerebral contusion and cerebrovascular accidents. J Neurol Sci (1982) 0.89
Deficiency of acetylcholine receptors in a case of end-plate acetylcholinesterase deficiency: a histochemical investigation. Muscle Nerve (1992) 0.89
A natural history study of late onset spinal muscular atrophy types 3b and 4. J Neurol (2008) 0.89
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens (2007) 0.89
Effects and side effects of a percutaneous thermal lesion of the dorsal root ganglion in patients with cervical pain syndrome. Pain (1993) 0.89
Neuroimages: local hyperhydrosis of the left forearm. Neurology (2000) 0.88
Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology. Respir Med (1999) 0.88
Progressive resistance training in neuromuscular patients. Effects on force and surface EMG. J Electromyogr Kinesiol (1999) 0.88
Developing a comprehensive presurgical functional MRI protocol for patients with intractable temporal lobe epilepsy: a pilot study. Neuroradiology (2002) 0.88
Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels. Clin Neurophysiol (2003) 0.88
Mimivirus is not a frequent cause of ventilator-associated pneumonia in critically ill patients. J Med Virol (2013) 0.88
Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J Neurochem (2001) 0.87
[Carpal tunnel syndrome: diagnosis, treatment, prevention and its relevance to dentistry]. Ned Tijdschr Tandheelkd (2009) 0.87
Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects. Clin Rehabil (1998) 0.87
Postural motor programming in paraplegic patients during rehabilitation. Ergonomics (1998) 0.87
Ritanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsy. Sleep (1991) 0.86
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches. Clin Pharmacol Ther (2000) 0.86
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J Suppl (2001) 0.86